Scarica l'app Stockscreener
178.71
0.04%
0.07
Dopo l'orario di chiusura:
178.71
Precedente Chiudi:
$178.64
Aprire:
$182.43
Volume 24 ore:
1.08M
Relative Volume:
0.51
Capitalizzazione di mercato:
$29.83B
Reddito:
$16.30B
Utile/perdita netta:
$1.36B
Rapporto P/E:
22.74
EPS:
7.8573
Flusso di cassa netto:
$2.05B
1 W Prestazione:
+13.27%
1M Prestazione:
+3.58%
6M Prestazione:
-15.09%
1 anno Prestazione:
+16.58%
Intervallo 1D:
$175.28
$182.62
Intervallo di 1 settimana:
$156.62
$182.70
Portata 52W:
$134.65
$247.04
Iqvia Holdings Inc Stock (IQV) Company Profile
Nome
Iqvia Holdings Inc
Settore
Industria
Telefono
919-998-2000
Indirizzo
2400 ELLIS ROAD, DURHAM, NC
Compare IQV vs TMO, DHR, IDXX, WAT, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
178.71 | 29.83B | 16.30B | 1.36B | 2.05B | 7.8573 |
TMO
Thermo Fisher Scientific Inc
|
465.00 | 172.80B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
171.16 | 121.14B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
560.11 | 44.18B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
355.13 | 34.86B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
115.62 | 32.67B | 7.07B | 1.29B | 993.00M | 4.5355 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-09 | Aggiornamento | TD Cowen | Hold → Buy |
| 2026-03-06 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2026-03-03 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-11-13 | Iniziato | BMO Capital Markets | Outperform |
| 2025-11-03 | Downgrade | TD Cowen | Buy → Hold |
| 2025-10-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-10-09 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-04-25 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-04-10 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-02-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-12-20 | Iniziato | Stephens | Overweight |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-09-04 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-07-24 | Downgrade | Jefferies | Buy → Hold |
| 2024-06-06 | Iniziato | Goldman | Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-15 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-02-13 | Iniziato | BTIG Research | Buy |
| 2023-11-02 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-03-17 | Iniziato | Truist | Buy |
| 2022-12-06 | Iniziato | Cowen | Outperform |
| 2022-11-17 | Downgrade | Citigroup | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-15 | Iniziato | SVB Leerink | Outperform |
| 2022-05-24 | Iniziato | Guggenheim | Buy |
| 2022-04-29 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-04-16 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2020-07-07 | Iniziato | Stephens | Equal-Weight |
| 2020-03-02 | Iniziato | Deutsche Bank | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-12-13 | Aggiornamento | CFRA | Sell → Hold |
| 2019-11-14 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | Aggiornamento | Mizuho | Neutral → Buy |
| 2019-05-28 | Iniziato | SVB Leerink | Outperform |
| 2019-01-18 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-10-09 | Iniziato | UBS | Buy |
| 2018-10-02 | Reiterato | Robert W. Baird | Outperform |
| 2018-07-25 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | Reiterato | Stifel | Buy |
| 2018-07-03 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-03-07 | Aggiornamento | SunTrust | Hold → Buy |
| 2018-01-19 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Iqvia Holdings Inc Borsa (IQV) Ultime notizie
Why IQVIA Holdings (IQV) Is Up 12.8% After Q1 Beat and Bigger Buyback Plan – And What's Next - simplywall.st
IQVIA Holdings stock (US46266C1053): Data?driven healthcare analytics in focus for US investors - AD HOC NEWS
IQVIA board authorizes additional $2B in share repurchases - MSN
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MSN
IQVIA Expands Share Repurchase Authorization by $2 Billion - The Globe and Mail
Here's why you should retain IQV stock in your portfolio now - MSN
BMO Capital Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $210 - Moomoo
IQVIA Holdings Inc. (NYSE:IQV) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year - simplywall.st
IQVIA Holdings | 8-K: Current report - Moomoo
Earnings Update: IQVIA Holdings Inc. (NYSE:IQV) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts - Yahoo Finance
IQVIA Increases Share Repurchase Authorization by $2 Billion, Bringing Total to $3.2 Billion 1 - Minichart
Artificial Intelligence in Epidemiology Market Is Going - openPR.com
IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization - The National Law Review
IQVIA Board Approves $2B Increase to Share Repurchase Authorization, $3.2B Remaining - TradingView
IQVIA board authorizes additional $2 billion stock buyback By Investing.com - Investing.com Australia
IQVIA (NYSE: IQV) boosts buyback plan, $3.2B now authorized - Stock Titan
8 Stocks Yet to Join the Rally With Upside Potential of Up to 85% - Investing.com
IQVIA Holdings (IQV) Q1 earnings and revenues beat estimates - MSN
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Contineum Therapeutics, Inc. Class A (CTNM) and Exelixis (EXEL) - The Globe and Mail
Barclays Sticks to Their Buy Rating for IQVIA Holdings (IQV) - The Globe and Mail
IQVIA Holdings (IQV) Earnings Growth And 8.3% Margin Keep Backlog Narrative In Question - Sahm
IQVIA CFO to Speak at Bank of America Health Care Conference 2026 - BioSpace
IQVIA Holdings Hits Day High with 9.62% Surge in Stock Price - Markets Mojo
Citigroup Maintains IQVIA Holdings (IQV) Neutral Recommendation - MSN
IQVIA Holdings | 8-K: IQVIA Reports First-Quarter 2026 Results - Moomoo
IQVIA Holdings Inc. announces an Increase in Equity Buyback. - marketscreener.com
IQVIA's Growth Setup Looks Positive After Q1 Beat, RBC Says - Moomoo
BMO Capital Maintains IQVIA Holdings(IQV.US) With Buy Rating, Cuts Target Price to $210 - Moomoo
Analysts Offer Insights on Healthcare Companies: Repligen (RGEN) and IQVIA Holdings (IQV) - The Globe and Mail
A Quick Look at Today's Ratings for IQVIA Holdings(IQV.US), With a Forecast Between $210 to $240 - Moomoo
Here's What Key Metrics Tell Us About IQVIA (IQV) Q1 Earnings - Yahoo Finance
IQVIA Holdings Inc. (NYSE:IQV) Q1 2026 Earnings Call Transcript - Insider Monkey
IQVIA Q1 2026 earnings preview - MSN
IQVIA shares drop as book-to-bill ratio misses expectations - Investing.com
TD Cowen Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $213 - Moomoo
Research Alert: CFRA Maintains Buy Rating On Shares Of Iqvia - Moomoo
IQVIA Holdings Inc. Q1 2026 Financial Results: Earnings, Balance Sheet, and SEC Filing Highlights - Minichart
IQVIA Q1 2026 slides: revenue climbs 8.4%, guidance raised By Investing.com - Investing.com South Africa
IQVIA jumps 9.6% as Q1 results top expectations and full-year EPS outlook rises - Quiver Quantitative
William Blair Maintains IQVIA Holdings(IQV.US) With Buy Rating - Moomoo
IQVIA HOLDINGS INC. 1Q 2026: Revenue $4.15B, EPS $1.61— 10-Q Summary - TradingView
IQVIA Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
IQVIA (NYSE: IQV) grows Q1 2026 revenue to $4.15B and boosts EPS - Stock Titan
IQVIA signals raised 2026 adjusted EPS outlook to $12.65-$12.95 while reaffirming $17.150B-$17.350B revenue - MSN
IQVIA Holdings Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:IQV) 2026-05-05 - Seeking Alpha
IQVIA Holdings Inc Stock (IQV) Closed Up by 9.60% on May 5: Key Drivers Unveiled - TradingKey
IQVIA Holdings (IQV) Q1 2026 Earnings Call Transcript - Fortune
Trending Industry Today: IQVIA Holdings Leads Gains In CRO Stocks - Moomoo
IQV Q1 Earnings Beat on Commercial Solutions Strength - TradingView
IQVIA Holdings Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
IQVIA Q1 2026 slides: revenue climbs 8.4%, guidance raised - Investing.com
Iqvia Holdings Inc Azioni (IQV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
11.64%
1.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):